Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Personalized medicine: Genetic risk prediction of drug response. | Pharmacol Ther | 2017 | 28213088 | PubTator, text mining | PubMed |
| Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis. | Clin Infect Dis | 2017 | 28205671 | PubTator, text mining | PubMed |
| Association between NAT2 polymorphisms and the risk of schizophrenia in a Northern Chinese Han population. | Psychiatr Genet | 2017 | 28187106 | PubTator, text mining | PubMed |
| Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group. | Clin Lab | 2017 | 28182356 | PubTator, text mining | PubMed |
| Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells. | Arch Toxicol | 2017 | 28160022 | PubTator, text mining | PubMed |
| A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations. | PLoS Comput Biol | 2017 | 28151932 | PubTator, text mining | PubMed |
| Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. | Biomed Res Int | 2017 | 28133614 | PubTator, text mining | PubMed |
| Drug-induced liver injury: Towards early prediction and risk stratification. | World J Hepatol | 2017 | 28105256 | PubTator, text mining | PubMed |
| The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. | Clin Pharmacol Ther | 2017 | 28090649 | PubTator, text mining | PubMed |
| Cornerstones of Toxicology. | Toxicol Pathol | 2017 | 28068892 | PubTator, text mining | PubMed |
| Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients. | Eur Urol | 2017 | 28040354 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines. | Ann Lab Med | 2017 | 28029011 | PubTator, text mining | PubMed |
| Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations. | Ann Lab Med | 2017 | 28028995 | PubTator, text mining | PubMed |
| Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury? | Pharm Res | 2017 | 28028769 | PubTator, text mining | PubMed |
| Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers. | Food Chem Toxicol | 2017 | 28011360 | PubTator, text mining | PubMed |
| Characterization of ADME gene variation in 21 populations by exome sequencing. | Pharmacogenet Genomics | 2017 | 27984508 | PubTator, text mining | PubMed |
| Distribution of xenobiotic metabolising enzyme genotypes in different Tunisian populations. | Ann Hum Biol | 2017 | 27978766 | PubTator, text mining | PubMed |
| Metabolism of the Tobacco Carcinogen 2-Amino-9H-pyrido[2,3-b]indole (AαC) in Primary Human Hepatocytes. | Chem Res Toxicol | 2017 | 27976871 | PubTator, text mining | PubMed |
| A perspective of chronic low exposure of arsenic on non-working women: Risk of hypertension. | Sci Total Environ | 2017 | 27951440 | PubTator, text mining | PubMed |
| Genomic variants, genes, and pathways of Alzheimer's disease: An overview. | Am J Med Genet B Neuropsychiatr Genet | 2017 | 27943641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=67